Go Pro

Science Applications International (SAIC) Financials

Science Applications International logo
$133.19 -0.46 (-0.34%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$133.08 -0.11 (-0.08%)
As of 09/18/2026 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Science Applications International

Annual Income Statements for Science Applications International

This table shows Science Applications International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025 1/30/2026
Net Income / (Loss) Attributable to Common Shareholders
117 143 179 137 226 209 277 300 477 362 358
Consolidated Net Income / (Loss)
117 143 179 137 229 211 279 303 477 362 358
Net Income / (Loss) Continuing Operations
117 143 179 137 229 211 279 303 477 362 358
Total Pre-Tax Income
183 212 214 170 286 271 358 375 620 428 387
Total Operating Income
227 263 256 220 370 390 462 501 741 563 521
Total Gross Profit
411 439 411 464 706 792 859 888 872 892 872
Total Revenue
4,315 4,442 4,454 4,659 6,379 7,056 7,394 7,704 7,444 7,479 7,262
Operating Revenue
4,315 4,442 4,454 4,659 6,379 7,056 7,394 7,704 7,444 7,479 7,262
Total Cost of Revenue
3,904 4,003 4,043 4,195 5,673 6,264 6,535 6,816 6,572 6,587 6,390
Operating Cost of Revenue
3,904 4,003 4,043 4,195 5,673 6,264 6,535 6,816 6,572 6,587 6,390
Total Operating Expenses
184 176 155 244 336 402 397 387 131 329 351
Selling, General & Admin Expense
184 166 155 158 288 352 344 374 373 339 350
Other Operating Expenses / (Income)
- - - 0.00 0.00 -4.00 -1.00 13 -2.00 -10 1.00
Other Special Charges / (Income)
- - - - - - -2.00 0.00 -240 0.00 0.00
Total Other Income / (Expense), net
-44 -51 -42 -50 -84 -119 -104 -126 -121 -135 -134
Interest Expense
44 52 44 53 90 122 105 118 120 126 128
Other Income / (Expense), net
0.00 1.00 2.00 3.00 6.00 3.00 1.00 -8.00 -1.00 -9.00 -6.00
Income Tax Expense
66 69 35 33 57 60 79 72 143 66 29
Basic Earnings per Share
$2.55 $3.21 $4.13 $3.16 $3.87 $3.60 $4.81 $5.42 $8.98 $7.23 $7.73
Weighted Average Basic Shares Outstanding
45.90M 43.57M 43.30M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Diluted Earnings per Share
$2.47 $3.12 $4.02 $3.11 $3.83 $3.56 $4.77 $5.38 $8.88 $7.17 $7.70
Weighted Average Diluted Shares Outstanding
45.90M 43.57M 43.30M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Weighted Average Basic & Diluted Shares Outstanding
45.90M 43.57M 43.30M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Cash Dividends to Common per Share
$1.21 $1.24 $1.24 $1.24 $1.48 $1.48 $1.48 $1.48 $1.48 $1.48 $1.48

Quarterly Income Statements for Science Applications International

This table shows Science Applications International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 2/2/2024 5/3/2024 8/2/2024 11/1/2024 1/31/2025 5/2/2025 8/1/2025 10/31/2025 1/30/2026 5/1/2026 7/31/2026
Net Income / (Loss) Attributable to Common Shareholders
39 77 81 106 98 68 127 78 85 115 102
Consolidated Net Income / (Loss)
39 77 81 106 98 68 127 78 85 115 102
Net Income / (Loss) Continuing Operations
39 77 81 106 98 68 127 78 85 115 102
Total Pre-Tax Income
48 95 100 126 107 86 108 94 99 145 119
Total Operating Income
79 131 134 160 138 121 139 128 133 179 152
Total Gross Profit
192 213 210 237 232 209 215 227 221 249 239
Total Revenue
1,737 1,847 1,818 1,976 1,838 1,877 1,769 1,866 1,750 1,906 1,880
Operating Revenue
1,737 1,847 1,818 1,976 1,838 1,877 1,769 1,866 1,750 1,906 1,880
Total Cost of Revenue
1,545 1,634 1,608 1,739 1,606 1,668 1,554 1,639 1,529 1,657 1,641
Operating Cost of Revenue
1,545 1,634 1,608 1,739 1,606 1,668 1,554 1,639 1,529 1,657 1,641
Total Operating Expenses
113 82 76 77 94 88 76 99 88 70 87
Selling, General & Admin Expense
114 85 77 83 94 89 75 101 85 83 87
Other Operating Expenses / (Income)
-1.00 -3.00 -1.00 -6.00 - -1.00 1.00 -2.00 3.00 -13 0.00
Total Other Income / (Expense), net
-31 -36 -34 -34 -31 -35 -31 -34 -34 -34 -33
Interest Expense
32 34 31 32 29 30 31 33 34 33 33
Other Income / (Expense), net
1.00 -2.00 -3.00 -2.00 -2.00 -5.00 0.00 -1.00 - -1.00 0.00
Income Tax Expense
9.00 18 19 20 9.00 18 -19 16 14 30 17
Basic Earnings per Share
$0.79 $1.49 $1.59 $2.15 $2.00 $1.43 $2.72 $1.70 $1.88 $2.63 $2.41
Weighted Average Basic Shares Outstanding
51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M 41.90M
Diluted Earnings per Share
$0.77 $1.48 $1.58 $2.13 $1.98 $1.42 $2.71 $1.69 $1.88 $2.61 $2.38
Weighted Average Diluted Shares Outstanding
51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M 41.90M
Weighted Average Basic & Diluted Shares Outstanding
51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M 41.90M

Annual Cash Flow Statements for Science Applications International

This table details how cash moves in and out of Science Applications International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025 1/30/2026
Net Change in Cash & Equivalents
-92 9.00 -66 94 -44 -12 -75 3.00 -15 -39 126
Net Cash From Operating Activities
226 273 217 184 458 755 518 532 396 494 609
Net Cash From Continuing Operating Activities
226 273 217 184 458 755 518 532 396 494 609
Net Income / (Loss) Continuing Operations
117 143 179 137 229 211 279 303 477 362 358
Consolidated Net Income / (Loss)
117 143 179 137 229 211 279 303 477 362 358
Depreciation Expense
62 53 46 47 131 179 165 157 142 140 149
Non-Cash Adjustments To Reconcile Net Income
24 16 27 85 42 54 62 47 -185 46 65
Changes in Operating Assets and Liabilities, net
23 61 -35 -87 49 305 38 25 -38 -54 37
Net Cash From Investing Activities
-784 -17 -22 -1,028 -47 -1,231 -292 -36 314 -35 -248
Net Cash From Continuing Investing Activities
-784 -17 -22 -1,028 -47 -1,231 -292 -36 314 -35 -248
Purchase of Property, Plant & Equipment
-20 -15 -22 -28 -21 -46 -36 -25 -27 -36 -32
Acquisitions
-764 0.00 0.00 -1,001 0.00 -1,202 -255 0.00 -8.00 0.00 -203
Purchase of Investments
- - 0.00 0.00 -24 -6.00 -9.00 -7.00 -18 -21 -20
Divestitures
- - - 0.00 0.00 17 8.00 0.00 356 10 0.00
Sale and/or Maturity of Investments
- - 0.00 0.00 3.00 9.00 6.00 4.00 6.00 12 7.00
Other Investing Activities, net
- -2.00 0.00 1.00 -5.00 -3.00 -6.00 -8.00 5.00 0.00 0.00
Net Cash From Financing Activities
466 -247 -261 938 -455 464 -301 -493 -725 -498 -235
Net Cash From Continuing Financing Activities
466 -247 -261 938 -455 464 -301 -493 -725 -498 -235
Repayment of Debt
-89 -238 -50 -805 -274 -426 -119 -999 -441 -1,384 -2,487
Repurchase of Common Equity
-69 -180 -186 -71 -197 -34 -226 -267 -382 -558 -445
Payment of Dividends
-55 -54 -54 -52 -94 -89 -88 -83 -79 -75 -70
Issuance of Debt
670 209 25 1,859 100 1,000 116 840 160 1,499 2,745
Issuance of Common Equity
4.00 5.00 6.00 7.00 10 13 16 16 17 20 22
Cash Interest Paid
36 48 41 44 86 96 98 111 125 121 101

Quarterly Cash Flow Statements for Science Applications International

This table details how cash moves in and out of Science Applications International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 2/2/2024 5/3/2024 8/2/2024 11/1/2024 1/31/2025 5/2/2025 8/1/2025 10/31/2025 1/30/2026 5/1/2026 7/31/2026
Net Change in Cash & Equivalents
-217 -45 -2.00 -2.00 10 -9.00 1.00 -3.00 137 -73 17
Net Cash From Operating Activities
63 98 138 143 115 100 122 129 258 127 146
Net Cash From Continuing Operating Activities
63 98 136 143 115 100 122 129 258 127 146
Net Income / (Loss) Continuing Operations
39 77 81 106 98 68 127 78 85 115 102
Consolidated Net Income / (Loss)
39 77 81 106 98 68 127 78 85 115 102
Depreciation Expense
36 35 34 35 36 36 35 38 40 40 39
Non-Cash Adjustments To Reconcile Net Income
24 12 8.00 7.00 17 16 10 22 18 -1.00 13
Changes in Operating Assets and Liabilities, net
-36 -26 13 -5.00 -36 -20 -50 -9.00 115 -27 -8.00
Net Cash From Investing Activities
-10 -7.00 -9.00 1.00 -20 -15 -7.00 -215 -11 1.00 -15
Net Cash From Continuing Investing Activities
-10 -7.00 -9.00 1.00 -20 -15 -7.00 -215 -11 1.00 -15
Purchase of Property, Plant & Equipment
-11 -6.00 -6.00 -9.00 -15 -8.00 -7.00 -9.00 -8.00 -9.00 -15
Purchase of Investments
-2.00 -4.00 -4.00 -3.00 -3.00 -4.00 - -1.00 -15 -4.00 -14
Sale and/or Maturity of Investments
1.00 4.00 2.00 4.00 2.00 3.00 1.00 1.00 2.00 20 6.00
Other Investing Activities, net
5.00 -1.00 -1.00 -1.00 -4.00 -6.00 -1.00 -3.00 10 -6.00 8.00
Net Cash From Financing Activities
-270 -136 -131 -146 -85 -94 -114 83 -110 -201 -114
Net Cash From Continuing Financing Activities
-270 -136 -131 -146 -85 -94 -114 83 -110 -201 -114
Repayment of Debt
-166 -310 -296 -450 -328 -689 -550 -1,247 -1.00 -1.00 -5.00
Repurchase of Common Equity
-89 -103 -201 -121 -133 -142 -110 -95 -98 -188 -98
Payment of Dividends
-19 -20 -19 -18 -18 -19 -17 -17 -17 -17 -16
Issuance of Common Equity
4.00 4.00 5.00 5.00 6.00 6.00 6.00 4.00 6.00 5.00 5.00

Annual Balance Sheets for Science Applications International

This table presents Science Applications International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025 1/30/2026
Total Assets
2,122 2,042 2,073 4,563 4,711 5,723 5,746 5,543 5,314 5,246 5,354
Total Current Assets
952 901 950 1,433 1,430 1,289 1,263 1,197 1,131 1,154 1,179
Cash & Equivalents
195 210 144 237 188 171 106 109 94 56 182
Accounts Receivable
635 539 674 1,050 1,099 962 1,015 936 914 1,000 853
Prepaid Expenses
21 27 35 47 40 56 57 58 93 78 122
Other Current Assets
33 54 29 25 19 22 21 23 30 20 22
Plant, Property, & Equipment, net
71 60 61 103 91 108 100 92 91 104 110
Total Noncurrent Assets
1,099 1,081 1,062 3,027 3,190 4,326 4,383 4,254 4,092 3,988 4,065
Goodwill
860 863 863 2,120 2,139 2,787 2,913 2,911 2,851 2,851 2,944
Intangible Assets
224 200 179 803 711 1,138 1,132 1,009 894 779 761
Other Noncurrent Operating Assets
15 18 20 104 340 401 338 320 347 358 360
Total Liabilities & Shareholders' Equity
2,122 2,042 2,073 4,563 4,711 5,723 5,746 5,543 5,314 5,246 5,354
Total Liabilities
1,742 1,693 1,746 3,064 3,284 4,171 4,117 3,839 3,529 3,669 3,854
Total Current Liabilities
688 623 695 897 1,128 1,275 1,352 1,126 1,158 1,396 982
Short-Term Debt
57 25 41 24 70 68 148 31 77 313 19
Accounts Payable
351 329 397 455 527 517 612 624 567 631 500
Accrued Expenses
280 269 257 297 405 494 365 266 265 233 147
Current Employee Benefit Liabilities
- - - 121 126 196 227 205 249 219 316
Total Noncurrent Liabilities
1,054 1,070 1,051 2,167 2,156 2,896 2,765 2,713 2,371 2,273 2,872
Long-Term Debt
1,013 1,022 983 2,065 1,851 2,447 2,370 2,343 2,022 1,907 2,468
Noncurrent Deferred & Payable Income Tax Liabilities
8.00 10 23 - - 2.00 43 0.00 28 24 104
Other Noncurrent Operating Liabilities
33 38 45 102 305 447 352 370 321 342 300
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
380 349 327 1,499 1,427 1,552 1,629 1,704 1,785 1,577 1,500
Total Preferred & Common Equity
380 349 327 1,485 1,417 1,542 1,619 1,694 1,785 1,577 1,500
Total Common Equity
380 349 327 1,485 1,417 1,542 1,619 1,694 1,785 1,577 1,500
Common Stock
215 91 0.00 1,132 983 1,004 838 637 337 0.00 0.00
Retained Earnings
174 260 323 367 506 627 818 1,035 1,432 1,565 1,492
Accumulated Other Comprehensive Income / (Loss)
-9.00 -2.00 4.00 -14 -72 -89 -37 22 16 12 8.00

Quarterly Balance Sheets for Science Applications International

This table presents Science Applications International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026 Q1 2027 Q2 2027
Period end date 5/5/2023 8/4/2023 11/3/2023 5/3/2024 8/2/2024 11/1/2024 5/2/2025 8/1/2025 10/31/2025 5/1/2026 7/31/2026
Total Assets
5,957 5,672 5,658 5,250 5,250 5,275 5,211 5,201 5,423 5,338 5,423
Total Current Assets
1,675 1,384 1,388 1,091 1,103 1,160 1,148 1,204 1,257 1,199 1,279
Cash & Equivalents
422 352 311 49 48 46 47 48 45 109 126
Accounts Receivable
995 958 1,010 934 946 1,022 1,009 951 1,045 962 996
Prepaid Expenses
77 74 67 108 109 92 92 175 145 102 129
Other Current Assets
- - - - - - - 30 22 26 28
Plant, Property, & Equipment, net
91 90 89 93 95 99 102 104 108 111 122
Total Noncurrent Assets
4,191 4,198 4,181 4,066 4,052 4,016 3,961 3,893 4,058 4,028 4,022
Goodwill
2,851 2,851 2,851 2,851 2,851 2,851 2,851 2,851 2,960 2,944 2,943
Intangible Assets
980 951 923 865 836 807 750 721 779 729 697
Other Noncurrent Operating Assets
360 396 407 350 365 358 360 321 319 355 382
Total Liabilities & Shareholders' Equity
5,957 5,672 5,658 5,250 5,250 5,275 5,211 5,201 5,423 5,338 5,423
Total Liabilities
4,265 3,829 3,830 3,491 3,625 3,663 3,706 3,684 3,911 3,915 3,987
Total Current Liabilities
1,553 1,212 1,226 1,154 1,292 1,337 1,474 1,447 1,050 1,037 1,062
Short-Term Debt
46 62 69 90 197 220 405 448 12 26 33
Accounts Payable
809 820 840 648 639 714 668 557 627 634 597
Accrued Expenses
- - - 129 118 92 113 106 103 99 98
Current Employee Benefit Liabilities
277 330 317 287 338 311 288 336 308 278 334
Total Noncurrent Liabilities
2,712 2,617 2,604 2,337 2,333 2,326 2,232 2,237 2,861 2,878 2,925
Long-Term Debt
2,329 2,215 2,194 1,993 1,970 1,939 1,876 1,844 2,475 2,460 2,452
Noncurrent Deferred & Payable Income Tax Liabilities
- - - 29 19 12 22 132 124 125 147
Other Noncurrent Operating Liabilities
383 402 410 315 344 375 334 261 262 293 326
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,692 1,843 1,828 1,759 1,625 1,612 1,505 1,517 1,512 1,423 1,436
Total Preferred & Common Equity
1,692 1,843 1,828 1,759 1,625 1,612 1,505 1,517 1,512 1,423 1,436
Total Common Equity
1,692 1,843 1,828 1,759 1,625 1,612 1,505 1,517 1,512 1,423 1,436
Common Stock
563 480 395 251 63 0.00 0.00 0.00 0.00 0.00 0.00
Retained Earnings
1,113 1,340 1,413 1,489 1,551 1,602 1,494 1,508 1,504 1,416 1,429
Accumulated Other Comprehensive Income / (Loss)
16 23 20 19 11 10 11 9.00 8.00 7.00 7.00

Annual Metrics And Ratios for Science Applications International

This table displays calculated financial ratios and metrics derived from Science Applications International's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 1/29/2016 2/3/2017 2/2/2018 2/1/2019 1/31/2020 1/29/2021 1/28/2022 2/3/2023 2/2/2024 1/31/2025 1/30/2026
DEI Shares Outstanding
- - - - - - - - - - 45,127,414.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 45,127,414.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 7.93
Growth Metrics
- - - - - - - - - - -
Profitability Metrics
- - - - - - - - - - -
Net Operating Profit after Tax (NOPAT)
145 177 214 177 296 304 360 405 570 476 482
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.93% 14.68% 12.54% 12.09%
Earnings before Interest and Taxes (EBIT)
227 264 258 223 376 393 463 493 740 554 515
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
289 317 304 272 514 578 602 650 882 694 664
Valuation Ratios
- - - - - - - - - - -
Leverage & Solvency
- - - - - - - - - - -
Liquidity Ratios
- - - - - - - - - - -
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-580 246 193 -1,967 487 -432 215 477 749 525 418
Efficiency Ratios
- - - - - - - - - - -
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,255 1,186 1,207 3,351 3,160 3,896 4,041 3,969 3,790 3,741 3,805
Increase / (Decrease) in Invested Capital
725 -69 21 2,144 -191 736 145 -72 -179 -49 64
Book Value per Share
$8.36 $7.95 $7.65 $34.90 $24.55 $26.48 $28.43 $31.01 $34.29 $32.26 $33.24
Tangible Book Value per Share
($15.48) ($16.27) ($16.72) ($33.80) ($24.83) ($40.93) ($42.61) ($40.75) ($37.65) ($42.00) ($48.86)
Total Capital
1,450 1,396 1,351 3,588 3,348 4,067 4,147 4,078 3,884 3,797 3,987
Total Debt
1,070 1,047 1,024 2,089 1,921 2,515 2,518 2,374 2,099 2,220 2,487
Total Long-Term Debt
1,013 1,022 983 2,065 1,851 2,447 2,370 2,343 2,022 1,907 2,468
Net Debt
875 837 880 1,852 1,733 2,344 2,412 2,265 2,005 2,164 2,305
Capital Expenditures (CapEx)
20 15 22 28 21 46 36 25 27 36 32
Debt-free, Cash-free Net Working Capital (DFCFNWC)
126 93 152 323 184 -89 -47 -7.00 -44 15 34
Debt-free Net Working Capital (DFNWC)
321 303 296 560 372 82 59 102 50 71 216
Net Working Capital (NWC)
264 278 255 536 302 14 -89 71 -27 -242 197
Net Nonoperating Expense (NNE)
28 34 35 40 67 93 81 102 93 114 124
Net Nonoperating Obligations (NNO)
875 837 880 1,852 1,733 2,344 2,412 2,265 2,005 2,164 2,305
Total Depreciation and Amortization (D&A)
62 53 46 49 138 185 139 157 142 140 149
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$2.55 $3.33 $4.13 $3.16 $3.87 $3.60 $4.81 $5.42 $8.98 $7.23 $7.73
Adjusted Weighted Average Basic Shares Outstanding
44.78M 43.57M 42.28M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Adjusted Diluted Earnings per Share
$2.47 $3.22 $4.02 $3.11 $3.83 $3.56 $4.77 $5.38 $8.88 $7.17 $7.70
Adjusted Weighted Average Diluted Shares Outstanding
44.78M 43.57M 42.28M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $4.13 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
44.78M 43.57M 42.28M 59.32M 57.84M 58.07M 56.05M 54.20M 51.65M 47.74M 43.42M
Normalized Net Operating Profit after Tax (NOPAT)
145 184 214 247 335 346 402 405 385 476 482
Debt Service Ratios
- - - - - - - - - - -
Payout Ratios
- - - - - - - - - - -

Quarterly Metrics And Ratios for Science Applications International

This table displays calculated financial ratios and metrics derived from Science Applications International's official financial filings.

Metric Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026 Q1 2027 Q2 2027
Period end date 2/2/2024 5/3/2024 8/2/2024 11/1/2024 1/31/2025 5/2/2025 8/1/2025 10/31/2025 1/30/2026 5/1/2026 7/31/2026
DEI Shares Outstanding
- - - - - - - - 45,127,414.00 43,419,313.00 42,276,819.00
DEI Adjusted Shares Outstanding
- - - - - - - - 45,127,414.00 43,419,313.00 42,276,819.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - 1.88 2.65 2.41
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-11.74% -8.93% 1.91% 4.27% 5.81% 1.62% -2.70% -5.57% - 1.55% 6.27%
EBITDA Growth
-25.16% -14.14% -58.75% 10.29% 48.28% -7.32% 5.45% -14.51% - 43.42% 9.77%
EBIT Growth
-31.03% -16.77% -64.01% 12.06% 70.00% -10.08% 6.11% -19.62% - 53.45% 9.35%
NOPAT Growth
-38.35% -15.12% -59.33% 15.38% 96.91% -9.89% 50.59% -21.09% - 48.38% -20.29%
Net Income Growth
-48.00% -21.43% -67.21% 13.98% 151.28% -11.69% 56.79% -26.42% - 69.12% -19.69%
EPS Growth
-42.54% -17.32% -65.35% 21.02% 157.14% -4.05% 71.52% -20.66% - 83.80% -12.18%
Operating Cash Flow Growth
-56.55% 19.51% -8.00% 41.58% 82.54% 2.04% -11.59% -9.79% - 27.00% 19.67%
Free Cash Flow Firm Growth
38.08% -124.12% -74.26% -46.24% -27.88% 195.44% 10.50% -164.76% - -45.91% -34.26%
Invested Capital Growth
-4.51% 7.45% -0.64% -1.46% -1.29% -1.42% 0.45% 6.15% - 1.63% 0.90%
Revenue Q/Q Growth
-8.34% 6.33% -1.57% 8.69% -6.98% 2.12% -5.75% 5.48% - 8.91% -1.36%
EBITDA Q/Q Growth
-33.71% 41.38% 0.61% 16.97% -10.88% -11.63% 14.47% -5.17% - 26.01% -12.39%
EBIT Q/Q Growth
-43.26% 61.25% 1.55% 20.61% -13.92% -14.71% 19.83% -8.63% - 33.83% -14.61%
NOPAT Q/Q Growth
-44.98% 65.42% 2.22% 24.01% -6.10% -24.30% 70.84% -35.02% - 24.32% -8.23%
Net Income Q/Q Growth
-58.06% 97.44% 5.19% 30.86% -7.55% -30.61% 86.76% -38.58% - 35.29% -11.30%
EPS Q/Q Growth
-56.25% 92.21% 6.76% 34.81% -7.04% -28.28% 90.85% -37.64% - 38.83% -8.81%
Operating Cash Flow Q/Q Growth
-37.62% 55.56% 40.82% 3.62% -19.58% -13.04% 22.00% 5.74% - -50.78% 14.96%
Free Cash Flow Firm Q/Q Growth
-31.04% -164.49% 184.52% 43.05% -7.49% -14.66% -2.15% -183.84% - 61.31% 18.92%
Invested Capital Q/Q Growth
0.26% 0.08% -1.29% -0.51% 0.43% -0.05% 0.59% 5.13% - -0.13% -0.13%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
11.05% 11.53% 11.55% 11.99% 12.62% 11.13% 12.15% 12.17% - 13.06% 12.71%
EBITDA Margin
6.68% 8.88% 9.08% 9.77% 9.36% 8.10% 9.84% 8.84% - 11.44% 10.16%
Operating Margin
4.55% 7.09% 7.37% 8.10% 7.51% 6.45% 7.86% 6.86% - 9.39% 8.09%
EBIT Margin
4.61% 6.98% 7.21% 8.00% 7.40% 6.18% 7.86% 6.81% - 9.34% 8.09%
Profit (Net Income) Margin
2.25% 4.17% 4.46% 5.36% 5.33% 3.62% 7.18% 4.18% - 6.03% 5.43%
Tax Burden Percent
81.25% 81.05% 81.00% 84.13% 91.59% 79.07% 117.59% 82.98% - 79.31% 85.71%
Interest Burden Percent
60.00% 73.64% 76.34% 79.75% 78.68% 74.14% 77.70% 74.02% - 81.46% 78.29%
Effective Tax Rate
18.75% 18.95% 19.00% 15.87% 8.41% 20.93% -17.59% 17.02% - 20.69% 14.29%
Return on Invested Capital (ROIC)
7.09% 11.40% 11.60% 13.39% 13.66% 10.16% 18.37% 10.90% - 14.41% 13.58%
ROIC Less NNEP Spread (ROIC-NNEP)
5.91% 9.90% 10.24% 11.99% 12.30% 8.87% 16.70% 9.66% - 13.24% 12.35%
Return on Net Nonoperating Assets (RNNOA)
7.23% 11.10% 11.94% 14.16% 15.25% 11.59% 23.19% 14.08% - 20.85% 19.25%
Return on Equity (ROE)
14.32% 22.51% 23.54% 27.56% 28.91% 21.76% 41.56% 24.98% - 35.25% 32.83%
Cash Return on Invested Capital (CROIC)
19.31% 7.86% 11.17% 12.49% 13.95% 13.80% 13.44% 6.90% - 12.33% 12.13%
Operating Return on Assets (OROA)
6.32% 9.05% 9.63% 10.79% 10.48% 8.87% 11.22% 9.35% - 12.91% 11.27%
Return on Assets (ROA)
3.08% 5.40% 5.95% 7.24% 7.55% 5.20% 10.25% 5.74% - 8.34% 7.56%
Return on Common Equity (ROCE)
14.28% 22.51% 23.54% 27.56% 28.91% 21.76% 41.56% 24.98% - 35.25% 32.83%
Return on Equity Simple (ROE_SIMPLE)
0.00% 25.92% 17.85% 18.80% 0.00% 23.46% 0.00% 0.00% - 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
64 106 109 135 126 96 163 106 114 142 130
NOPAT Margin
3.70% 5.75% 5.97% 6.81% 6.88% 5.10% 9.24% 5.69% - 7.45% 6.93%
Net Nonoperating Expense Percent (NNEP)
1.18% 1.51% 1.36% 1.41% 1.36% 1.30% 1.67% 1.24% - 1.17% 1.23%
Return On Investment Capital (ROIC_SIMPLE)
1.65% 2.76% - - 3.33% 2.53% 4.29% 2.66% 2.86% 3.63% 3.32%
Cost of Revenue to Revenue
88.95% 88.47% 88.45% 88.01% 87.38% 88.87% 87.85% 87.83% - 86.94% 87.29%
SG&A Expenses to Revenue
6.56% 4.60% 4.24% 4.20% 5.11% 4.74% 4.24% 5.41% - 4.35% 4.63%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Operating Expenses to Revenue
6.51% 4.44% 4.18% 3.90% 5.11% 4.69% 4.30% 5.31% - 3.67% 4.63%
Earnings before Interest and Taxes (EBIT)
80 129 131 158 136 116 139 127 133 178 152
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
116 164 165 193 172 152 174 165 173 218 191
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.72 3.82 3.88 4.44 3.36 3.74 3.42 2.85 - 2.93 3.45
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Price to Revenue (P/Rev)
0.89 0.92 0.86 0.97 0.71 0.75 0.70 0.59 - 0.57 0.67
Price to Earnings (P/E)
13.91 14.72 21.73 23.64 14.62 15.95 13.01 11.62 - 10.28 13.03
Dividend Yield
1.16% 1.14% 1.20% 1.02% 1.37% 1.25% 1.34% 1.58% - 1.54% 1.26%
Earnings Yield
7.19% 6.79% 4.60% 4.23% 6.84% 6.27% 7.69% 8.60% - 9.73% 7.67%
Enterprise Value to Invested Capital (EV/IC)
2.28 2.31 2.25 2.49 1.99 2.10 1.98 1.71 - 1.72 1.93
Enterprise Value to Revenue (EV/Rev)
1.16 1.20 1.15 1.26 1.00 1.05 1.00 0.92 - 0.90 0.99
Enterprise Value to EBITDA (EV/EBITDA)
9.80 10.23 13.58 14.54 10.74 11.53 10.76 10.19 - 8.96 9.79
Enterprise Value to EBIT (EV/EBIT)
11.68 12.25 17.51 18.63 13.46 14.54 13.54 13.04 - 11.34 12.39
Enterprise Value to NOPAT (EV/NOPAT)
15.16 15.88 21.29 22.42 15.66 16.88 14.26 13.67 - 12.44 14.85
Enterprise Value to Operating Cash Flow (EV/OCF)
21.82 21.23 21.05 20.99 15.09 15.86 15.49 14.50 - 10.29 11.08
Enterprise Value to Free Cash Flow (EV/FCFF)
11.54 30.39 20.07 19.79 14.20 15.13 14.74 25.49 - 14.07 15.95
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.18 1.18 1.33 1.34 1.41 1.52 1.51 1.64 - 1.75 1.73
Long-Term Debt to Equity
1.13 1.13 1.21 1.20 1.21 1.25 1.22 1.64 - 1.73 1.71
Financial Leverage
1.22 1.12 1.17 1.18 1.24 1.31 1.39 1.46 - 1.57 1.56
Leverage Ratio
3.11 3.25 3.15 3.18 3.14 3.21 3.33 3.42 - 3.60 3.60
Compound Leverage Factor
1.87 2.39 2.40 2.53 2.47 2.38 2.58 2.53 - 2.93 2.82
Debt to Total Capital
54.04% 54.22% 57.15% 57.25% 58.47% 60.25% 60.17% 62.19% - 63.60% 63.38%
Short-Term Debt to Total Capital
1.98% 2.34% 5.20% 5.83% 8.24% 10.70% 11.76% 0.30% - 0.67% 0.84%
Long-Term Debt to Total Capital
52.06% 51.87% 51.95% 51.42% 50.22% 49.55% 48.41% 61.89% - 62.93% 62.54%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Common Equity to Total Capital
45.96% 45.78% 42.85% 42.75% 41.53% 39.75% 39.83% 37.81% - 36.40% 36.62%
Debt to EBITDA
2.38 2.44 3.50 3.38 3.20 3.34 3.32 3.75 - 3.41 3.33
Net Debt to EBITDA
2.27 2.38 3.42 3.31 3.12 3.28 3.25 3.68 - 3.26 3.16
Long-Term Debt to EBITDA
2.29 2.33 3.18 3.04 2.75 2.75 2.67 3.73 - 3.37 3.28
Debt to NOPAT
3.68 3.78 5.48 5.22 4.66 4.90 4.40 5.03 - 4.73 5.05
Net Debt to NOPAT
3.52 3.69 5.36 5.11 4.54 4.80 4.30 4.94 - 4.52 4.79
Long-Term Debt to NOPAT
3.55 3.62 4.98 4.69 4.00 4.03 3.54 5.01 - 4.68 4.98
Altman Z-Score
2.95 3.00 2.89 3.06 2.74 2.75 2.72 2.53 - 2.52 2.62
Noncontrolling Interest Sharing Ratio
0.29% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
0.98 0.95 0.85 0.87 0.83 0.78 0.83 1.20 - 1.16 1.20
Quick Ratio
0.87 0.85 0.77 0.80 0.76 0.72 0.69 1.04 - 1.03 1.06
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
243 -157 133 190 175 150 146 -123 50 81 96
Operating Cash Flow to CapEx
572.73% 1,633.33% 2,300.00% 1,588.89% 766.67% 1,250.00% 1,742.86% 1,433.33% - 1,411.11% 973.33%
Free Cash Flow to Firm to Interest Expense
7.60 -4.61 4.28 5.93 6.05 4.99 4.72 -3.72 - 2.45 2.92
Operating Cash Flow to Interest Expense
1.97 2.88 4.45 4.47 3.97 3.33 3.94 3.91 - 3.85 4.42
Operating Cash Flow Less CapEx to Interest Expense
1.63 2.71 4.26 4.19 3.45 3.07 3.71 3.64 - 3.58 3.97
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.37 1.30 1.34 1.35 1.42 1.44 1.43 1.37 - 1.38 1.39
Accounts Receivable Turnover
8.05 7.53 7.66 7.26 7.82 7.73 7.87 7.11 - 7.40 7.60
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Fixed Asset Turnover
81.36 78.95 78.89 78.49 76.71 77.02 74.97 71.01 - 68.46 65.50
Accounts Payable Turnover
11.04 8.80 8.85 8.40 11.00 10.06 10.98 9.65 - 9.80 11.21
Days Sales Outstanding (DSO)
45.36 48.47 47.62 50.26 46.70 47.22 46.41 51.32 - 49.34 48.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Days Payable Outstanding (DPO)
33.07 41.46 41.26 43.46 33.19 36.27 33.24 37.84 - 37.25 32.57
Cash Conversion Cycle (CCC)
12.28 7.01 6.36 6.81 13.51 10.95 13.17 13.48 - 12.09 15.43
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
3,790 3,793 3,744 3,725 3,741 3,739 3,761 3,954 3,805 3,800 3,795
Invested Capital Turnover
1.92 1.98 1.94 1.97 1.99 1.99 1.99 1.91 - 1.93 1.96
Increase / (Decrease) in Invested Capital
-179 263 -24 -55 -49 -54 17 229 64 61 34
Enterprise Value (EV)
8,642 8,745 8,422 9,277 7,457 7,866 7,434 6,755 - 6,541 7,311
Market Capitalization
6,637 6,711 6,303 7,164 5,293 5,632 5,190 4,313 - 4,164 4,952
Book Value per Share
$34.29 $34.06 $31.72 $32.55 $32.26 $31.53 $32.36 $32.85 $33.24 $32.77 $33.97
Tangible Book Value per Share
($37.65) ($37.89) ($40.25) ($41.32) ($42.00) ($43.91) ($43.84) ($48.39) ($48.86) ($51.82) ($52.13)
Total Capital
3,884 3,842 3,792 3,771 3,797 3,786 3,809 3,999 3,987 3,909 3,921
Total Debt
2,099 2,083 2,167 2,159 2,220 2,281 2,292 2,487 2,487 2,486 2,485
Total Long-Term Debt
2,022 1,993 1,970 1,939 1,907 1,876 1,844 2,475 2,468 2,460 2,452
Net Debt
2,005 2,034 2,119 2,113 2,164 2,234 2,244 2,442 2,305 2,377 2,359
Capital Expenditures (CapEx)
11 6.00 6.00 9.00 15 8.00 7.00 9.00 8.00 9.00 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-44 -22 -40 -3.00 15 32 157 174 34 79 124
Debt-free Net Working Capital (DFNWC)
50 27 8.00 43 71 79 205 219 216 188 250
Net Working Capital (NWC)
-27 -63 -189 -177 -242 -326 -243 207 197 162 217
Net Nonoperating Expense (NNE)
25 29 28 29 28 28 36 28 29 27 28
Net Nonoperating Obligations (NNO)
2,005 2,034 2,119 2,113 2,164 2,234 2,244 2,442 2,305 2,377 2,359
Total Depreciation and Amortization (D&A)
36 35 34 35 36 36 35 38 40 40 39
Debt-free, Cash-free Net Working Capital to Revenue
-0.59% -0.30% -0.55% -0.04% 0.20% 0.43% 2.10% 2.37% - 1.08% 1.68%
Debt-free Net Working Capital to Revenue
0.67% 0.37% 0.11% 0.58% 0.95% 1.05% 2.75% 2.98% - 2.58% 3.38%
Net Working Capital to Revenue
-0.36% -0.87% -2.59% -2.40% -3.24% -4.34% -3.26% 2.82% - 2.22% 2.93%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.79 $1.49 $1.59 $2.15 $2.00 $1.43 $2.72 $1.70 $1.88 $2.63 $2.41
Adjusted Weighted Average Basic Shares Outstanding
51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M 41.90M
Adjusted Diluted Earnings per Share
$0.77 $1.48 $1.58 $2.13 $1.98 $1.42 $2.71 $1.69 $1.88 $2.61 $2.38
Adjusted Weighted Average Diluted Shares Outstanding
51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M 41.90M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
51.65M 51.23M 49.52M 48.88M 47.74M 46.87M 46.02M 45.13M 43.42M 42.28M 41.90M
Normalized Net Operating Profit after Tax (NOPAT)
64 106 109 135 126 96 97 106 114 142 130
Normalized NOPAT Margin
3.70% 5.75% 5.97% 6.81% 6.88% 5.10% 5.50% 5.69% - 7.45% 6.93%
Pre Tax Income Margin
2.76% 5.14% 5.50% 6.38% 5.82% 4.58% 6.11% 5.04% - 7.61% 6.33%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
2.50 3.79 4.23 4.94 4.69 3.87 4.48 3.85 - 5.39 4.61
NOPAT to Interest Expense
2.01 3.12 3.50 4.21 4.36 3.19 5.27 3.22 - 4.30 3.95
EBIT Less CapEx to Interest Expense
2.16 3.62 4.03 4.66 4.17 3.60 4.26 3.58 - 5.12 4.15
NOPAT Less CapEx to Interest Expense
1.66 2.95 3.31 3.93 3.84 2.92 5.05 2.95 - 4.03 3.49
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
16.56% 17.11% 26.55% 25.08% 20.72% 20.96% 18.05% 19.14% - 16.79% 17.63%
Augmented Payout Ratio
96.65% 104.17% 197.59% 194.72% 174.86% 190.09% 144.86% 148.52% - 138.02% 143.68%

Financials Breakdown Chart

Key Financial Trends

Science Applications International (NASDAQ: SAIC) delivered mixed but generally resilient results in Q2 fiscal 2027. Revenue was $1.88 billion, down 1.4% from Q1 but up approximately 6.3% from the restated Q2 fiscal 2026. Net income declined to $102 million from $115 million in the prior quarter, while diluted EPS fell to $2.38 from $2.61. Over the broader period, quarterly revenue has remained below the $2.03 billion peak reported in Q1 fiscal 2024, although profitability has held up comparatively well.

Margins improved sequentially from the weaker Q4 fiscal 2026 quarter. Gross profit was $239 million, representing a gross margin of approximately 12.7%, while operating income was $152 million, or 8.1% of revenue. Operating margin improved from 7.6% in Q4 but was below Q1 fiscal 2027's 9.4%. Interest expense remained significant at $33 million, limiting the conversion of operating income into net earnings.

Cash generation remains one of SAIC's strongest financial characteristics. Operating cash flow increased to $146 million in Q2 from $127 million in Q1, and capital expenditures were $15 million, implying approximate quarterly free cash flow of $131 million. The company used $98 million for share repurchases and paid $16 million in dividends, while still ending the quarter with $126 million of cash, up from $109 million at the end of Q1.

The balance sheet is more leveraged than it was in earlier periods. SAIC had approximately $2.49 billion of total debt at the end of Q2, compared with $2.29 billion in Q2 fiscal 2026, against $126 million of cash. Current assets of $1.28 billion exceeded current liabilities of $1.06 billion, but goodwill and intangible assets totaled approximately $3.64 billion, or roughly two-thirds of total assets. Investors should therefore monitor debt reduction, interest costs and the carrying value of acquisition-related assets.

  • Revenue recovered year over year: Q2 fiscal 2027 revenue of $1.88 billion was approximately 6.3% above the restated year-ago quarter, reversing some of the weakness seen after the fiscal 2024 revenue peak.
  • Operating profitability remains solid: The latest 8.1% operating margin improved from Q4 fiscal 2026 and remains above several earlier quarters in the data set.
  • Consistent positive cash generation: Operating cash flow was $146 million and estimated free cash flow was approximately $131 million in Q2, providing funding for capital returns and debt service.
  • Share count has declined substantially: Weighted average diluted shares fell to 41.9 million from 51.2 million in Q1 fiscal 2025 and 47.7 million in Q4 fiscal 2025, reflecting sustained repurchases that can support per-share results.
  • Cash reserves improved sequentially: Cash and equivalents increased from $45 million in Q3 fiscal 2026 to $126 million in Q2 fiscal 2027 despite continued buybacks and dividends.
  • Liquidity is adequate but not excessive: Current assets exceeded current liabilities by $217 million, producing a current ratio of approximately 1.2, while accounts receivable remained high at $996 million.
  • Capital returns remain a priority: SAIC returned $114 million through repurchases and dividends in Q2, a shareholder-friendly policy that also consumes cash that could otherwise reduce debt.
  • Quarterly earnings momentum weakened: Net income fell 11.3% sequentially and diluted EPS declined from $2.61 to $2.38, even though revenue decreased only modestly.
  • Interest expense continues to pressure earnings: Quarterly interest expense has generally remained around $30 million to $34 million, including $33 million in Q2, reflecting the company's substantial debt load.
  • Leverage and intangible-asset concentration remain risks: Total debt of approximately $2.49 billion was nearly 1.8 times shareholders' equity, while goodwill and intangible assets represented approximately 67% of total assets, increasing sensitivity to refinancing conditions and potential impairment charges.
09/19/26 05:18 PM ETAI Generated. May Contain Errors.

Science Applications International Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Science Applications International's fiscal year ends in January. Their fiscal year 2026 ended on January 30, 2026.

Science Applications International's net income appears to be on an upward trend, with a most recent value of $358 million in 2026, rising from $117 million in 2016. The previous period was $362 million in 2025. Find out what analysts predict for Science Applications International in the coming months.

Science Applications International's total operating income in 2026 was $521 million, based on the following breakdown:
  • Total Gross Profit: $872 million
  • Total Operating Expenses: $351 million

Over the last 10 years, Science Applications International's total revenue changed from $4.32 billion in 2016 to $7.26 billion in 2026, a change of 68.3%.

Science Applications International's total liabilities were at $3.85 billion at the end of 2026, a 5.0% increase from 2025, and a 121.2% increase since 2016.

In the past 10 years, Science Applications International's cash and equivalents has ranged from $56 million in 2025 to $237 million in 2019, and is currently $182 million as of their latest financial filing in 2026.

Over the last 10 years, Science Applications International's book value per share changed from 8.36 in 2016 to 33.24 in 2026, a change of 297.7%.



Financial statements for NASDAQ:SAIC last updated on 8/31/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners